Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody
José Luís Hernández(Leitat Technological Center), Ramón Messeguer(Leitat Technological Center)
Cited by 107
Related Papers
S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
|Oncogenesis|2014|61
Endo and exo cyclopalladated (E)-N-([1,1'-biphenyl]-2-yl)-1-mesitylmethanimines: Anticancer, antibacterial and antioxidant activities
|Journal of Organometallic Chemistry|2017|10